Has Jeff Lookhart received payments from drug or device companies?

Yes. Drug and device makers reported $3,015 in general payments to Jeff Lookhart across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeff Lookhart did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeff Lookhart come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeff Lookhart

Optometrist · Independence, MONPI 1770619660

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,225 and has fallen 96.7% since, to $40 in 2025.

$3,015in general payments, 2019–2025

Across 101 payments — averaging $29.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$496
Biotissue Holdings Inc.$489
Sight Sciences, Inc.$437
Bausch & Lomb, A Division Of Bausch Health US, LLC$354
Aerie Pharmaceuticals, Inc.$193
Novartis$173
plus $872 from 14 others

What the payments were for

Food & beverage$3,015100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	14	$496
Biotissue Holdings Inc.	8	$489
Sight Sciences, Inc.	15	$437
Bausch & Lomb, A Division Of Bausch Health US, LLC	10	$354
Aerie Pharmaceuticals, Inc.	11	$193
Novartis	10	$173
Mallinckrodt Enterprises LLC	4	$152
Alcon	1	$133
Dompe US, Inc.	1	$108
Johnson & Johnson Vision Care, Inc.	6	$97
Mallinckrodt Hospital Products Inc.	5	$93
Kala Pharmaceuticals, Inc.	4	$70
Sun Pharmaceutical Industries Inc.	3	$66
Bausch & Lomb Americas Inc.	2	$44
Oyster Point Pharma, Inc.	2	$35
Eyevance Pharmaceuticals LLC	1	$20
ANI Pharmaceuticals, Inc.	1	$19
Shire North American Group Inc	1	$13
Eyepoint US, Inc.	1	$12
Ocular Therapeutix, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,015 in reported general payments places this provider in the 85th percentile of 1,030 optometrist providers in Missouri.

See all optometrist providers in Missouri →

Other optometrist in Independence

Jessica HillnerIndependence$11K
Sarah SalimIndependence$7K
Andrew BiondoKirkwood$300K
John McGrealSaint Louis$126K
Alana KellerWildwood$94K
Sarah HubbardChesterfield$91K
Ariel CerenzieSaint Louis$76K
Geoffrey PowellKansas City$55K
Thomas HobbsSedalia$53K
Heather WebsterColumbia$52K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →